case_images: PMC7086429_01
case_images: PMC7086429_02
case_images: (a) Case 1: 8Fr pigtail catheter secured by SAS; the exit site is sealed with cyanoacrylate glue; a small piece of gauze is placed under the SAS device; the whole area is covered with transparent semipermeable membrane. (b) Case 2: same securement as in (a). (c) Case 3: 8Fr trocar catheter secured by SAS; the exit site is sealed with cyanoacrylate glue and covered with transparent membrane.
case_images: CRIPE2020-7480483.001.jpg
case_images: PMC7086429_04_CRIPE2020-7480483.001.jpg
case_images: fig1
case_images: At day 15, a relevant pleural effusion was detected in the left pleural space. At day 17, the clinical conditions worsened, and an 8Fr catheter (Trocar) was placed into the pleural space under ultrasound guidance, anchored with an 8Fr SAS; the exit site of the catheter was sealed with sterile cyanoacrylate glue and covered with transparent semipermeable dressing (Figure 1(c)).
case_images: PMC7086429_03
case_images: (a) Case 1: 8Fr pigtail catheter secured by SAS; the exit site is sealed with cyanoacrylate glue; a small piece of gauze is placed under the SAS device; the whole area is covered with transparent semipermeable membrane. (b) Case 2: same securement as in (a). (c) Case 3: 8Fr trocar catheter secured by SAS; the exit site is sealed with cyanoacrylate glue and covered with transparent membrane.
case_images: CRIPE2020-7480483.001.jpg
case_images: PMC7086429_04_CRIPE2020-7480483.001.jpg
case_images: fig1
case_images: At day 15, a relevant pleural effusion was detected in the left pleural space. At day 17, the clinical conditions worsened, and an 8Fr catheter (Trocar) was placed into the pleural space under ultrasound guidance, anchored with an 8Fr SAS; the exit site of the catheter was sealed with sterile cyanoacrylate glue and covered with transparent semipermeable dressing (Figure 1(c)).
case_images: PMC7086429_04
case_images: (a) Case 1: 8Fr pigtail catheter secured by SAS; the exit site is sealed with cyanoacrylate glue; a small piece of gauze is placed under the SAS device; the whole area is covered with transparent semipermeable membrane. (b) Case 2: same securement as in (a). (c) Case 3: 8Fr trocar catheter secured by SAS; the exit site is sealed with cyanoacrylate glue and covered with transparent membrane.
case_images: CRIPE2020-7480483.001.jpg
case_images: PMC7086429_04_CRIPE2020-7480483.001.jpg
case_images: fig1
case_images: At day 15, a relevant pleural effusion was detected in the left pleural space. At day 17, the clinical conditions worsened, and an 8Fr catheter (Trocar) was placed into the pleural space under ultrasound guidance, anchored with an 8Fr SAS; the exit site of the catheter was sealed with sterile cyanoacrylate glue and covered with transparent semipermeable dressing (Figure 1(c)).